title: Why open drug discovery needs four simple rules for licensing data and models.
abstract: When we look at the rapid growth of scientific databases on the Internet in the past decade, we tend to take the accessibility and provenance of the data for granted. As we see a future of increased database integration, the licensing of the data may be a hurdle that hampers progress and usability. We have formulated four rules for licensing data for open drug discovery, which we propose as a starting point for consideration by databases and for their ultimate adoption. This work could also be extended to the computational models derived from such data. We suggest that scientists in the future will need to consider data licensing before they embark upon re-using such content in databases they construct themselves.
authors.affiliation: Royal Society of Chemistry, Wake Forest, North Carolina, USA. tony27587@gmail.com
authors.forename: Antony J
authors.initials: AJ
authors.lastname: Williams
authors.forename: John
authors.initials: J
authors.lastname: Wilbanks
authors.forename: Sean
authors.initials: S
authors.lastname: Ekins
mesh_terms: D000465:Algorithms; D003628:Database Management Systems; D062313:Databases, Pharmaceutical; D055808:Drug Discovery; D033181:Information Dissemination / Q000379:methods*; D008004:Licensure; D008962:Models, Theoretical; D014584:User-Computer Interface